Skip to main content
Top
Published in: International Urology and Nephrology 3/2010

01-09-2010 | Nephrology - Review

Does Arkadia contribute to TGF-β1-induced IgA expression through up-regulation of Smad signaling in IgA nephropathy?

Authors: Xiao-Zhao Li, Jun-Tao Feng, Cheng-Ping Hu, Ze-Qi Chen

Published in: International Urology and Nephrology | Issue 3/2010

Login to get access

Abstract

Immunoglobulin A nephropathy (IgAN) is an immune-complex-mediated glomerulonephritis characterized by the presence of IgA deposits in mesangial and paramesangial regions. However, the exact mechanism involved in IgA deposition is still unknown. TGF-β1 that mediates the progression of IgAN is well established as a critical IgA class (isotype) switching factor, and Smad proteins are critical intracellular mediators in the expression of TGF-β1-targeted genes, which suggest that TGF-β signaling has been implicated in the primary pathogenesis of IgAN. Arkadia, an E3 ubiquitin ligase, can amplify TGF-β signaling through regulating Smads degradation. When these findings are considered together, it is of interest to explore how Arkadia and Smad signaling affect TGF-β1-induced IgA expression in IgAN. Therefore, we propose that Arkadia could positively contribute to TGF-β1-induced IgA secretion through up-regulation of Smad signaling in the pathogenesis of IgAN.
Literature
1.
go back to reference Schena FP (1990) A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am J Med 9(2):209–225 Schena FP (1990) A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am J Med 9(2):209–225
2.
3.
go back to reference Sporn MB, Roberts AB (1992) Transforming growth factor-beta: recent progress and new challenges. J Cell Biol 119(5):1017–1021CrossRefPubMed Sporn MB, Roberts AB (1992) Transforming growth factor-beta: recent progress and new challenges. J Cell Biol 119(5):1017–1021CrossRefPubMed
4.
go back to reference Del Prete D, Gambaro G, Lupo A et al (2003) Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. Kidney Int 64(1):149–159CrossRefPubMed Del Prete D, Gambaro G, Lupo A et al (2003) Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. Kidney Int 64(1):149–159CrossRefPubMed
5.
go back to reference Leung JC, Chan LY, Tsang AW et al (2004) Anti-macrophage migration inhibitory factor reduces transforming growth factor-beta 1 expression in experimental IgA nephropathy. Nephrol Dial Transplant 19(8):1976–1985CrossRefPubMed Leung JC, Chan LY, Tsang AW et al (2004) Anti-macrophage migration inhibitory factor reduces transforming growth factor-beta 1 expression in experimental IgA nephropathy. Nephrol Dial Transplant 19(8):1976–1985CrossRefPubMed
6.
go back to reference Zhong Q, Leung JC, Chan LY et al (2005) The study of Chinese medicinal herbal formula Shen San Fang in the treatment of experimental IgA nephropathy. Am J Chin Med 33(4):613–626CrossRefPubMed Zhong Q, Leung JC, Chan LY et al (2005) The study of Chinese medicinal herbal formula Shen San Fang in the treatment of experimental IgA nephropathy. Am J Chin Med 33(4):613–626CrossRefPubMed
7.
go back to reference Chihara Y, Ono H, Ishimitsu T et al (2006) Roles of TGF-β1 and apoptosis in the progression of glomerulosclerosis in human IgA nephropathy. Clin Nephrol 65(6):385–392PubMed Chihara Y, Ono H, Ishimitsu T et al (2006) Roles of TGF-β1 and apoptosis in the progression of glomerulosclerosis in human IgA nephropathy. Clin Nephrol 65(6):385–392PubMed
8.
go back to reference Border WA, Noble NA (1997) TGF-beta in kidney fibrosis: a target for gene therapy. Kidney Int 51:1388–1396CrossRefPubMed Border WA, Noble NA (1997) TGF-beta in kidney fibrosis: a target for gene therapy. Kidney Int 51:1388–1396CrossRefPubMed
9.
go back to reference Border WA, Noble NA, Yamamoto T et al (1992) Antagonists of transforming growth factor-beta: a novel approach to treatment of glomerulonephritis and prevention of glomerulosclerosis. Kidney Int 41(3):566–570CrossRefPubMed Border WA, Noble NA, Yamamoto T et al (1992) Antagonists of transforming growth factor-beta: a novel approach to treatment of glomerulonephritis and prevention of glomerulosclerosis. Kidney Int 41(3):566–570CrossRefPubMed
11.
go back to reference Zhang Y, Derynck R (2000) Transcriptional regulation of the transforming growth factor-beta -inducible mouse germ line Ig alpha constant region gene by functional cooperation of Smad, CREB, and AML family members. J Biol Chem 275(22):16979–16985CrossRefPubMed Zhang Y, Derynck R (2000) Transcriptional regulation of the transforming growth factor-beta -inducible mouse germ line Ig alpha constant region gene by functional cooperation of Smad, CREB, and AML family members. J Biol Chem 275(22):16979–16985CrossRefPubMed
12.
go back to reference Kaminski DA, Stavnezer J (2007) Stimuli that enhance IgA class switching increase histone 3 acetylation at S alpha, but poorly stimulate sequential switching from IgG2b. Eur J Immunol 37(1):240–251CrossRefPubMed Kaminski DA, Stavnezer J (2007) Stimuli that enhance IgA class switching increase histone 3 acetylation at S alpha, but poorly stimulate sequential switching from IgG2b. Eur J Immunol 37(1):240–251CrossRefPubMed
13.
go back to reference Park SR, Seo GY, Choi AJ et al (2005) Analysis of transforming growth factor-beta1-induced Ig germ-line gamma2b transcription and its implication for IgA isotype switching. Eur J Immunol 35(3):946–956CrossRefPubMed Park SR, Seo GY, Choi AJ et al (2005) Analysis of transforming growth factor-beta1-induced Ig germ-line gamma2b transcription and its implication for IgA isotype switching. Eur J Immunol 35(3):946–956CrossRefPubMed
14.
go back to reference Pardali E, Xie XQ, Tsapogas P et al (2000) Smad and AML proteins synergistically confer transforming growth factor beta1 responsiveness to human germ-line IgA genes. J Biol Chem 275(5):3552–3560CrossRefPubMed Pardali E, Xie XQ, Tsapogas P et al (2000) Smad and AML proteins synergistically confer transforming growth factor beta1 responsiveness to human germ-line IgA genes. J Biol Chem 275(5):3552–3560CrossRefPubMed
15.
go back to reference Lebman DA, Lee FD, Coffman RL (1990) Mechanism for transforming growth factor beta and IL-2 enhancement of IgA expression in lipopolysaccharide-stimulated B cell cultures. J Immunol 144(3):952–959PubMed Lebman DA, Lee FD, Coffman RL (1990) Mechanism for transforming growth factor beta and IL-2 enhancement of IgA expression in lipopolysaccharide-stimulated B cell cultures. J Immunol 144(3):952–959PubMed
16.
go back to reference Kim PH, Kagnoff MF (1990) Transforming growth factor-beta 1 is a costimulator for IgA production. J Immunol 144(9):3411–3416PubMed Kim PH, Kagnoff MF (1990) Transforming growth factor-beta 1 is a costimulator for IgA production. J Immunol 144(9):3411–3416PubMed
17.
go back to reference Van Ginkel FW, Wahl SM, Kearney JF et al (1999) Partial IgA-deficiency with increased Th2-type cytokines in TGF-beta1 knockout mice. J Immuno l163(4):1951–1957 Van Ginkel FW, Wahl SM, Kearney JF et al (1999) Partial IgA-deficiency with increased Th2-type cytokines in TGF-beta1 knockout mice. J Immuno l163(4):1951–1957
18.
go back to reference Moustakas A, Souchelnytskyi S, Heldin CH (2001) Smad regulation in TGF-beta signal transduction. J Cell Sci 114(24):4359–4369PubMed Moustakas A, Souchelnytskyi S, Heldin CH (2001) Smad regulation in TGF-beta signal transduction. J Cell Sci 114(24):4359–4369PubMed
19.
go back to reference Park SR, Lee JH, Kim PH (2001) Smad3 and Smad4 mediate transforming growth factor-beta1-induced IgA expression in murine B lymphocytes. Eur J Immunol 31(6):1706–1715CrossRefPubMed Park SR, Lee JH, Kim PH (2001) Smad3 and Smad4 mediate transforming growth factor-beta1-induced IgA expression in murine B lymphocytes. Eur J Immunol 31(6):1706–1715CrossRefPubMed
20.
go back to reference Lai KN, Tang SC, Guh JY et al (2003) Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-beta synthesis and signal transduction in human mesangial cells via the renin-angiotensin system. J Am Soc Nephrol 14(12):3127–3137CrossRefPubMed Lai KN, Tang SC, Guh JY et al (2003) Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-beta synthesis and signal transduction in human mesangial cells via the renin-angiotensin system. J Am Soc Nephrol 14(12):3127–3137CrossRefPubMed
21.
go back to reference Kanamaru Y, Nakao A, Mamura M et al (2001) Blockade of TGF-beta signaling in T cells prevents the development of experimental glomerulonephritis. J Immunol 166(4):2818–2823PubMed Kanamaru Y, Nakao A, Mamura M et al (2001) Blockade of TGF-beta signaling in T cells prevents the development of experimental glomerulonephritis. J Immunol 166(4):2818–2823PubMed
22.
go back to reference Nagano Y, Mavrakis KJ, Lee KL et al (2007) Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-beta signaling. J Biol Chem 282(28):20492–20501CrossRefPubMed Nagano Y, Mavrakis KJ, Lee KL et al (2007) Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-beta signaling. J Biol Chem 282(28):20492–20501CrossRefPubMed
23.
go back to reference Mavrakis KJ, Andrew RL, Lee KL et al (2007) Arkadia enhances Nodal/TGF-beta signaling by coupling phospho-Smad2/3 activity and turnover. PLoS Biol 5(3):e67CrossRefPubMed Mavrakis KJ, Andrew RL, Lee KL et al (2007) Arkadia enhances Nodal/TGF-beta signaling by coupling phospho-Smad2/3 activity and turnover. PLoS Biol 5(3):e67CrossRefPubMed
24.
go back to reference Levy L, Howell M, Das D et al (2007) Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation. Mol Cell Biol 27(17):6068–6083CrossRefPubMed Levy L, Howell M, Das D et al (2007) Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation. Mol Cell Biol 27(17):6068–6083CrossRefPubMed
25.
go back to reference Liu FY, Li XZ, Peng YM et al (2007) Arkadia-Smad7-mediated positive regulation of TGF-beta signaling in a rat model of tubulointerstitial fibrosis. Am J Nephrol 27(2):176–183PubMed Liu FY, Li XZ, Peng YM et al (2007) Arkadia-Smad7-mediated positive regulation of TGF-beta signaling in a rat model of tubulointerstitial fibrosis. Am J Nephrol 27(2):176–183PubMed
26.
go back to reference Liu FY, Li XZ, Peng YM et al (2008) Arkadia regulates TGF-beta signaling in renal tubular epithelial to mesenchymal cell transition. Kidney Int 73:588–594CrossRefPubMed Liu FY, Li XZ, Peng YM et al (2008) Arkadia regulates TGF-beta signaling in renal tubular epithelial to mesenchymal cell transition. Kidney Int 73:588–594CrossRefPubMed
27.
go back to reference Choi SH, Seo GY, Nam EH et al (2007) Opposing effects of Arkadia and Smurf on TGFbeta1-induced IgA isotype expression. Mol Cells 24(2):283–287PubMed Choi SH, Seo GY, Nam EH et al (2007) Opposing effects of Arkadia and Smurf on TGFbeta1-induced IgA isotype expression. Mol Cells 24(2):283–287PubMed
Metadata
Title
Does Arkadia contribute to TGF-β1-induced IgA expression through up-regulation of Smad signaling in IgA nephropathy?
Authors
Xiao-Zhao Li
Jun-Tao Feng
Cheng-Ping Hu
Ze-Qi Chen
Publication date
01-09-2010
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 3/2010
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-009-9682-2

Other articles of this Issue 3/2010

International Urology and Nephrology 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.